Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021

Authors

  • Nel Jason L Haw Health Sciences Program, Ateneo de Manila University, Quezon City, Philippines; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA https://orcid.org/0000-0003-2602-4214
  • Eugenia Mercedes Cañal Center for Health and Development, Region 7 (Central Visayas Region), Department of Health, Cebu City, Philippines
  • Juanito Zuasula Jr Center for Health and Development, Region 7 (Central Visayas Region), Department of Health, Cebu City, Philippines
  • Mary Jean Loreche Center for Health and Development, Region 7 (Central Visayas Region), Department of Health, Cebu City, Philippines
  • Jaime Bernadas Center for Health and Development, Region 7 (Central Visayas Region), Department of Health, Cebu City, Philippines

DOI:

https://doi.org/10.5365/wpsar.2022.13.1.883

Downloads

Published

09-02-2022

How to Cite

1.
Haw NJL, Cañal EM, Zuasula Jr J, Loreche MJ, Bernadas J. Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021. Western Pac Surveill Response J [Internet]. 2022 Feb. 9 [cited 2024 Nov. 23];13(1). Available from: https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/883

Issue

Vol. 13 No. 1 (2022): January ‒ March

Section

COVID-19: Brief Report

Categories